LDE-225
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LDE-225, covering 2019-06-25 to 2019-06-25. Get the full timeline:
Most recent: Clinical Trial Update: Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma [Phase 1, Phase 2]